1933 Industries AI Stock Analysis
Want to see TSE:TGIF full AI Analyst Report?
1933 Industries (TGIF) AI Stock Analysis
1933 Industries
(CNQX:TGIF)
The score is held down primarily by weak financial quality, especially the negative-equity balance sheet and inconsistent profitability. Technical momentum is also negative, while valuation offers some support through a low P/E ratio, but not enough to offset the higher fundamental risk.
1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 3.91M
- Dividend Yield
- ―
- Average Volume (3M)
- 208.80K
- Price to Earnings (P/E)
- 4.7
- Beta (1Y)
- -1.53
- Revenue Growth
- -4.90%
- EPS Growth
- ―
- Country
- Canada
- Employees
- 85
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
1933 Industries Business Overview & Revenue Model
Company Description
1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (CBD...
How the Company Makes Money
1933 Industries makes money primarily by selling cannabis products through regulated, state-licensed cannabis supply chains. Key revenue streams include: (1) wholesale and/or direct sales of company-produced cannabis products (including manufactured/...
1933 Industries Financial Statement Overview
Summary
Financial performance is weak overall. The income statement shows flat to declining revenue momentum and unstable profitability, while the balance sheet is the main risk with negative equity and high leverage. Cash flow is improving and is now positive, but the gains are still fragile and have not offset the structural balance sheet weakness.
Income Statement
38NegativeBalance Sheet
24NegativeCash Flow
52Neutral| Breakdown | TTM | Oct 2025 | Jan 2025 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.51M | 17.45M | 19.35M | 18.27M | 12.54M | 11.98M |
| Gross Profit | 169.46K | 5.16M | 2.94M | -4.22M | 2.69M | 4.82M |
| EBITDA | -2.02M | 1.01M | 313.67K | -10.03M | -13.83M | -2.71M |
| Net Income | 468.28K | -217.04K | -1.14M | -13.36M | -18.07M | -6.29M |
Balance Sheet | ||||||
| Total Assets | 15.53M | 16.80M | 16.87M | 18.02M | 29.01M | 45.35M |
| Cash, Cash Equivalents and Short-Term Investments | 536.57K | 545.98K | 449.18K | 1.09M | 363.27K | 4.41M |
| Total Debt | 15.57M | 17.60M | 16.78M | 17.57M | 17.68M | 17.87M |
| Total Liabilities | 18.80M | 21.40M | 21.70M | 23.28M | 21.49M | 20.12M |
| Stockholders Equity | -3.27M | -4.60M | -3.53M | -3.69M | 8.52M | 25.99M |
Cash Flow | ||||||
| Free Cash Flow | 1.91M | 1.67M | 801.71K | -2.33M | -5.10M | -5.12M |
| Operating Cash Flow | 2.08M | 1.84M | 1.69M | -1.53M | -5.09M | -4.67M |
| Investing Cash Flow | -318.84K | -169.22K | -890.78K | 2.33M | 1,581 | -456.36K |
| Financing Cash Flow | -2.02M | -1.58M | -1.46M | -266.55K | 1.53M | 6.06M |
1933 Industries Peers Comparison
Overall Rating
TSE:BBM44Neutral
TSE:TGIF43Neutral
TSE:DHB37Underperform
TSE:PCLO23Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | CAD 4.95M | -4.76 | -332.63% | ― | -36.67% | 40.54% | |
| 43Neutral | CAD 3.91M | 4.69 | -11.60% | ― | -4.90% | ― | |
| 37Underperform | CAD 2.81M | -1.25 | -67.83% | ― | -35.46% | -85.82% | |
| 23Underperform | CAD 8.41M | -2.41 | 28.59% | ― | 0.90% | 57.73% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:TGIF | 1933 Industries, Inc. | 0.01 | 0.00 | 0.00% | |
| TSE:DHB | Delivra Health Brands Inc. | 0.09 | -0.20 | -68.97% | |
| TSE:BBM | Blueberries Medical | 0.01 | -0.01 | -50.00% | |
| TSE:PCLO | Pharmacielo | 0.04 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jul 01, 2026
